Real-time enrollment status for this penile cancer clinical trial
Current Status
Active, Not Recruiting
Checked: September 1, 2026 at 5:54 AM UTC
| NCT Number | NCT02305654 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Penile Cancer |
| Phase | PHASE3 |
| Target Enrollment | 200 participants |
| Active Locations | 11 sites in the US |
| Sponsor | Institute of Cancer Research, United Kingdom |
| Last Updated on CT.gov | August 31, 2026 (Yesterday) |
As of September 1, 2026: Clinical trial NCT02305654 is currently active_not_recruiting participants. This phase3 study for penile cancer is not currently accepting new participants at 11 locations across the United States. The study is sponsored by Institute of Cancer Research, United Kingdom. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT02305654 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 11 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT02305654 was last updated Yesterday (August 31, 2026). HelloStudys verifies this status automatically.